Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in newborn screening for phenylketonuria.

R K Koch1

  • 1University of Southern California School of Medicine, Los Angeles, USA.

American Family Physician
|October 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

Early newborn screening for phenylketonuria (PKU) prevents intellectual disability. Prompt dietary intervention and repeat testing for infants with developmental delays are crucial for managing PKU effectively.

Area of Science:

  • Medical Genetics
  • Neonatal Screening
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is a genetic disorder that can lead to severe intellectual disability if untreated.
  • Newborn screening programs have significantly reduced the incidence of PKU-related cognitive impairment.
  • Early detection and intervention are critical for managing PKU and preventing its long-term consequences.

Purpose of the Study:

  • To emphasize the importance of timely blood sample collection for newborn screening.
  • To highlight the necessity of repeat testing for positive screening results and infants with developmental delays.
  • To underscore the role of specialized PKU centers and dietary management in preventing sequelae.

Main Methods:

  • Review of established protocols for newborn screening for phenylketonuria.

Related Experiment Videos

  • Analysis of the impact of early diagnosis and intervention on patient outcomes.
  • Discussion of the management strategies including dietary restrictions and the role of PKU centers.

    • Main Results:

    • Newborn screening for PKU, when conducted appropriately, largely prevents mental retardation.
    • Positive phenylalanine test results necessitate a repeat test for confirmation.
    • Delayed development in infants may indicate missed PKU cases, requiring further testing.

    Conclusions:

    • Timely blood sampling (at least 12 hours after birth) is essential for accurate newborn screening.
    • Consistent adherence to a phenylalanine-restricted diet, initiated early, is key to preventing PKU sequelae.
    • Ongoing vigilance, including repeat testing and specialized care, is vital for comprehensive PKU management.